We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

FDA Approves First Companion Diagnostic Test to Simultaneously Screen for Multiple Non-Small Cell Lung Cancer Therapies

News   Jun 23, 2017 | Original story from Thermo Fisher Scientific

 
FDA Approves First Companion Diagnostic Test to Simultaneously Screen for  Multiple Non-Small Cell Lung Cancer Therapies
 
 
Advertisement
 

RELATED ARTICLES

Avoiding Side Effects Associated With Cancer Treatment

News

Researchers at the University of California, Irvine and Switzerland's Lausanne University Hospital/University of Luassanne (CHUV/UNIL) may have found a way to treat cancer without the onset of debilitating side effects.

READ MORE

New Tactic To Stop the Growth of Glioblastoma

News

Scientists have discovered a way to halt the growth of glioblastoma, a deadly brain cancer. The team has devised a new tactic in the war against cancer that involves reprogramming the immune system to fight the tumor, rather than fueling it.

READ MORE

Spanish Study Explores Vitamin D Deficiency in COVID-19 Patients

News

Over 80 percent of 200 COVID-19 patients in a hospital in Spain have vitamin D deficiency, according to a new study.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Diagnostics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE